Award
National Cancer Institute 5U01CA296432-02
Characterizing genetic risk of cancer across diverse populations through multi-ancestry epigenome profiling and chromatin QTL discovery
Recipient
Dana-Farber Cancer Inst
Award Amount
$710,144.00
Ceiling
$710,144.00
Awarded
May 12, 2026
Identifier
5U01CA296432-02
Award for research to characterize genetic risk of cancer across diverse populations using epigenome profiling and chromatin QTL discovery, funded by the National Cancer Institute.
Description
The project aims to functionally characterize cancer-causing genetic variants in diverse populations with a focus on multi-ancestry epigenome profiling and chromatin QTL discovery. The project is funded for fiscal year 2026 with a duration from April 1, 2025, to March 31, 2030, under the study section "Cancer and Hematologic Disorders Study Section [CHD]".